Citi says CSL's CEO pick brings key strengths

By Reuters News

** Citi says CSL's incoming CEO brings commercial, pipeline development experience

** Australia's CSL CSL.AX appointed Deborah Waterhouse as permanent CEO, effective February 2027, after the bell on Wednesday

** Waterhouse is currently CEO of ViiV Healthcare, a joint venture majority-owned by GSK GSK.L

** Brokerage says Waterhouse's experience running a global business in a competitive HIV market bodes well for CSL

** Citi says its experience with Waterhouse suggests she has been thorough, consistent and has demonstrated sound commercial acumen

** Adds, Waterhouse was widely considered the "other" contender in GSK's recent CEO selection process and has worked across several of the company's businesses

** Citi says it is encouraged by the appointment, citing her track record and history of pipeline architecture

** CSL stock up 13% this year, as of last close

Capital Com is an execution-only service provider. The present material must be regarded as marketing communication and should not be interpreted as investment research or investment advice. Any opinion that may be provided on this page does not constitute a recommendation by Capital Com or its agents. We do not make any representations or warranty on the accuracy or completeness of the information that is provided on this page. If you rely on the information on this page, then you do so entirely at your own risk